Hepatotoxicity of newer antiseizure medications in children: an overview and disproportionality analysis of VigiBase

References

• Camfield P, Camfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 2015;17(2):117–23. doi: 10.1684/epd.2015.0736
   PubMed Web of Science ®Google Scholar
• Aaberg KM, Gunnes N, Bakken IJ, et al. Incidence and prevalence of childhood epilepsy: a nationwide cohort study. Pediatrics. 2017;139(5). doi: 10.1542/peds.2016-3908
   PubMed Web of Science ®Google Scholar
• Egunsola O, Choonara I, Sammons HM. Anti-epileptic drug utilisation in paediatrics: a systematic review. BMJ Paediatr Open. 2017;1(1):e000088. doi: 10.1136/bmjpo-2017-000088
   PubMedGoogle Scholar
• Yu L, Feng J, Yu Z, et al. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018. Epilepsy Res. 2020;167:106448. doi: 10.1016/j.eplepsyres.2020.106448
   PubMed Web of Science ®Google Scholar
• Weijenberg A, Bos JH, Schuiling-Veninga CC, et al. Antiepileptic drug prescription in Dutch children from 2006–2014 using pharmacy-dispensing data. Epilepsy Res. 2018;146:21–27. doi: 10.1016/j.eplepsyres.2018.07.011
   PubMed Web of Science ®Google Scholar
• Liu X, Carney PR, Bussing R, et al. Trends in antiepileptic drug use in children and adolescents with epilepsy. Pediatr Neurol. 2017;74:32–40. doi: 10.1016/j.pediatrneurol.2017.05.016
   PubMed Web of Science ®Google Scholar
• Shi Q, Yang X, Greenhaw JJ, et al. Drug-induced liver injury in children: clinical observations, animal models, and regulatory status. Int J Toxicol. 2017;36(5):365–79. doi: 10.1177/1091581817721675
   PubMed Web of Science ®Google Scholar
• Amin MD, Harpavat S, Leung DH. Drug-induced liver injury in children. Curr Opin Pediatr. 2015;27(5):625–33. doi: 10.1097/MOP.0000000000000264
   PubMed Web of Science ®Google Scholar
• Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–8. e2. doi: 10.1016/j.jpeds.2005.12.051
   PubMed Web of Science ®Google Scholar
• DiPaola F, Molleston JP, Gu J, et al. Antimicrobials and anti-epileptics are the leading causes of idiosyncratic drug induced liver injury in American children. J Pediatr Gastroenterol Nutr. 2019;69(2):152–159. doi: 10.1097/MPG.0000000000002383
   PubMed Web of Science ®Google Scholar
• Devarbhavi H, Karanth D, KS P, et al. Drug‐Induced liver injury with hypersensitivity features has a better outcome: a single‐center experience of 39 children and adolescents. Hepatology. 2011;54(4):1344–1350. doi: 10.1002/hep.24527
   PubMed Web of Science ®Google Scholar
• Ferrajolo C, Capuano A, Verhamme KM, et al. Drug‐induced hepatic injury in children: a case/non‐case study of suspected adverse drug reactions in VigiBase. Br J Clin Pharmacol. 2010;70(5):721–728. doi: 10.1111/j.1365-2125.2010.03754.x
   PubMed Web of Science ®Google Scholar
• Guo Y-M, Ge F-L, Song H-B, et al. Relative risk analysis of liver-related adverse drug reactions in children based on China’s national spontaneous reporting system. J Pediatr. 2021;234:85–91. doi: 10.1016/j.jpeds.2021.03.044
   PubMed Web of Science ®Google Scholar
• Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340–52. e7. doi: 10.1053/j.gastro.2015.03.006
   PubMed Web of Science ®Google Scholar
• Devarbhavi H, Raj S, Aradya VH, et al. Drug‐induced liver injury associated with Stevens‐Johnson syndrome/toxic epidermal necrolysis: patient characteristics, causes, and outcome in 36 cases. Hepatology. 2016;63(3):993–999. doi: 10.1002/hep.28270
   PubMed Web of Science ®Google Scholar
• Stephens C, Robles-Diaz M, Medina-Caliz I, et al. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry. J Hepatol. 2021;75(1):86–97. doi: 10.1016/j.jhep.2021.01.029
   PubMed Web of Science ®Google Scholar
• Kuyucu S, Caubet J-C. Hypersensitivity reactions to antiepileptic drugs in children: epidemiologic, pathogenetic, clinical, and diagnostic aspects. J Allergy Clin Immunol Pract. 2018;6(6):1879–91. e1. doi: 10.1016/j.jaip.2018.07.003
   PubMed Web of Science ®Google Scholar
• Lindquist LM. VigiBase, the WHO global ICSR database system: basic facts. Drug Inf J. 2008;42(5):409–419. doi: 10.1177/009286150804200501
   Web of Science ®Google Scholar
• Petrović S, Kovačević M, Vezmar Kovačević S, et al. Drug-induced liver injury associated with the use of newer antiseizure medications in the elderly: an analysis of data from VigiBase. Expert Opin Drug Metab Toxicol. 2023;19(3):175–183. doi: 10.1080/17425255.2023.2203859
   PubMed Web of Science ®Google Scholar
• DuMouchel W, Pregibon D Empirical Bayes screening for multi-item associations. Proceedings of the seventh ACM SIGKDD international conference on Knowledge discovery and data mining; San Francisco. 2001. p. 67–76.
   Google Scholar
• Andrade RJ, Aithal GP, Björnsson ES, et al. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019;70(6):1222–1261. doi: 10.1016/j.jhep.2019.02.014
   PubMed Web of Science ®Google Scholar
• Molleston JP, Fontana RJ, Lopez MJ, et al. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study. J Pediatr Gastroenterol Nutr. 2011;53(2):182. doi: 10.1097/MPG.0b013e31821d6cfd
   PubMed Web of Science ®Google Scholar
• Sandritter TL, Goldman JL, Habiger CJ, et al. An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children. Sci Rep. 2019;9(1):18090. doi: 10.1038/s41598-019-54075-4
   PubMedGoogle Scholar
• Zhu Y, Li Y-G, Wang J-B, et al. Causes, features, and outcomes of drug-induced liver injury in 69 children from China. Gut Liver. 2015;9(4):525. doi: 10.5009/gnl14184
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Bonizzoni E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17(6):530–538. doi: 10.1016/S1474-4422(18)30107-8
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013;12(3):244–252. doi: 10.1016/S1474-4422(12)70323-X
   PubMed Web of Science ®Google Scholar
• Kikuchi D, Obara T, Kashiwagura S, et al. Trends in prescription of anti-seizure medicines for Japanese pediatric outpatients during 2013–2019. Epilepsy Behav Rep. 2021;16:100474. doi: 10.1016/j.ebr.2021.100474
   PubMedGoogle Scholar
• Heger K, Skipsfjord J, Kiselev Y, et al. Changes in the use of antiseizure medications in children and adolescents in Norway, 2009–2018. Epilepsy Res. 2022;181:106872. doi: 10.1016/j.eplepsyres.2022.106872
   PubMed Web of Science ®Google Scholar
• Kılıç B, Serdaroğlu E, Polat BG, et al. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: a retrospective multi-center study from Turkey between 2010 and 2020. Seizure. 2022;99:48–53. doi: 10.1016/j.seizure.2022.05.005
   PubMed Web of Science ®Google Scholar
• Hayashi PH, Rockey DC, Fontana RJ, et al. Death and liver transplantation within 2 years of onset of drug‐induced liver injury. Hepatology. 2017;66(4):1275–1285. doi: 10.1002/hep.29283
   PubMed Web of Science ®Google Scholar
• Devarbhavi H, Kurien SS, Raj S, et al. Idiosyncratic drug-induced liver injury associated with and without drug reaction with eosinophilia and systemic symptoms. Am J Gastroenterol. 2022;117(10):1709–1713. doi: 10.14309/ajg.0000000000001913
   PubMed Web of Science ®Google Scholar
• Lucena M, Medina-Caliz I, Almarza M, et al., editors. Clinical phenotype and outcome of dress cases in the Spanish and Latin-American dili registries. Proceedings for Annual Meeting of The Japanese Pharmacological Society WCP2018 (The 18th World Congress of Basic and Clinical Pharmacology); Kyoto, Japan. Japanese Pharmacological Society; 2018.
   Google Scholar
• Huang YS, Wu CY, Chang TT, et al. Drug‐induced liver injury associated with severe cutaneous adverse drug reactions: a nationwide study in Taiwan. Liver Int. 2021;41(11):2671–2680. doi: 10.1111/liv.14990
   PubMed Web of Science ®Google Scholar
• Guvenir H, Misirlioglu ED, Civelek E, et al. The frequency and clinical features of hypersensitivity reactions to antiepileptic drugs in children: a prospective study. J Allergy Clin Immunol Pract. 2018;6(6):2043–2050. doi: 10.1016/j.jaip.2018.02.018
   PubMed Web of Science ®Google Scholar
• Ordoñez L, Salgueiro E, Jimeno F, et al. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs. Eur Rev Med Pharmacol Sci. 2015;19(14):2732–2737.
   PubMed Web of Science ®Google Scholar
• Alfares I, Javaid MS, Chen Z, et al. Sex differences in the risk of cutaneous adverse drug reactions induced by antiseizure medications: a systematic review and meta-analysis. CNS Drugs. 2021;35(2):161–176. doi: 10.1007/s40263-021-00794-0
   PubMed Web of Science ®Google Scholar
• Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia. 2007;48(7):1360–1365. doi: 10.1111/j.1528-1167.2007.01109.x
   PubMed Web of Science ®Google Scholar
• Wang X-Q, Lang S-Y, Shi X-B, et al. Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy. Clin Neurol Neurosur. 2012;114(7):862–865. doi: 10.1016/j.clineuro.2012.01.019
   PubMed Web of Science ®Google Scholar
• Handoko KB, van Puijenbroek EP, Bijl AH, et al. Influence of chemical structure on hypersensitivity reactions induced by antiepileptic drugs: the role of the aromatic ring. Drug Saf. 2008;31(8):695. doi: 10.2165/00002018-200831080-00006
   PubMed Web of Science ®Google Scholar
• Spielberg SP, Gordon GB, Blake DA, et al. Anticonvulsant toxicity in vitro: possible role of arene oxides. J Pharmacol Exp Ther. 1981;217(2):386–389.
   PubMed Web of Science ®Google Scholar
• Pellock JM. Felbamate. Epilepsia. 1999;40(s5):s57–s62. doi: 10.1111/j.1528-1157.1999.tb00920.x
   PubMedGoogle Scholar
• Franco V, Barbieri MA, Cutroneo PM, et al. Pediatric adverse reactions to antiseizure medications–an analysis of data from the Italian spontaneous reporting system (2001–2019). Epilepsy Behav. 2021;119:107989. doi: 10.1016/j.yebeh.2021.107989
   PubMed Web of Science ®Google Scholar
• Attilakos A, Dinopoulos A, Paschalidou M, et al. Effect of levetiracetam monotherapy on liver enzymes and creatine kinase concentrations in children with epilepsy: a prospective study. J Clin Neurol. 2018;14(4):594–595. doi: 10.3988/jcn.2018.14.4.594
   PubMed Web of Science ®Google Scholar
• Rogalewski A, Zuhorn F, Wilkens L, et al. Severe drug-induced liver injury caused by levetiracetam–A case report and review of the literature. Epilepsy Behav Rep. 2021;16:100464. doi: 10.1016/j.ebr.2021.100464
   PubMedGoogle Scholar
• Friis M, Kristensen O, Boas J, et al. Therapeutic experiences with 947 epileptic out‐patients in oxcarbazepine treatment. Acta Neurol Scand. 1993;87(3):224–227. doi: 10.1111/j.1600-0404.1993.tb04106.x
   PubMed Web of Science ®Google Scholar
• Inoue Y, Ohtsuka Y, Group S-S. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: a multicenter, open-label study in Japan. Epilepsy Res. 2015;113:90–97. doi: 10.1016/j.eplepsyres.2015.03.012
   PubMed Web of Science ®Google Scholar
• Jogamoto T, Yamamoto Y, Fukuda M, et al. Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy. Epilepsy Res. 2017;130:7–12. doi: 10.1016/j.eplepsyres.2016.12.014
   PubMed Web of Science ®Google Scholar
• Tseng Y-L, Huang C-R, Lin C-H, et al. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy. Medicine. 2014;93(11):e66. doi: 10.1097/MD.0000000000000066
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Takahashi Y, Imai K, et al. Risk factors for hyperammonemia in pediatric patients with epilepsy. Epilepsia. 2013;54(6):983–989. doi: 10.1111/epi.12125
   PubMed Web of Science ®Google Scholar
• Tsien MZ, Cordova J, Qadir A, et al. Topiramate-induced acute liver failure in a pediatric patient: a case report and review of literature. J Pediatr Gastroenterol Nutr. 2016;63(3):e37–e8. doi: 10.1097/MPG.0000000000000566
   PubMedGoogle Scholar
• Noh Y, Kim DW, Chu K, et al. Topiramate increases the risk of valproic acid–induced encephalopathy. Epilepsia. 2013;54(1):e1–e4. doi: 10.1111/j.1528-1167.2012.03532.x
   PubMed Web of Science ®Google Scholar
• Hamer H, Knake S, Schomburg U, et al. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology. 2000;54(1):230–232. doi: 10.1212/WNL.54.1.230
   PubMed Web of Science ®Google Scholar
• Khouri C, Petit C, Tod M, et al. Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases. J Clin Epidemiol. 2021;134:14–21. doi: 10.1016/j.jclinepi.2021.01.015
   PubMed Web of Science ®Google Scholar
• García-Cortés M, Ortega-Alonso A, Lucena MI, et al. Drug-induced liver injury: a safety review. Expert Opin Drug Saf. 2018;17(8):795–804. doi: 10.1080/14740338.2018.1505861
   PubMed Web of Science ®Google Scholar
• Faillie J-L. Case–non-case studies: principle, methods, bias and interpretation. Therapie. 2019;74(2):225–232. doi: 10.1016/j.therap.2019.01.006
   PubMed Web of Science ®Google Scholar